Galmed Pharmaceuticals Ltd. buy Royal Bank of Canada
Start price
07.11.25
/
50%
€6.40
Target price
07.11.26
€79.74
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 07.11.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Galmed Pharmaceuticals Ltd. | - | - |
| iShares Core DAX® | 1.659% | 1.586% |
| iShares Nasdaq 100 | 0.381% | 1.900% |
| iShares Nikkei 225® | 2.102% | -1.377% |
| iShares S&P 500 | 0.221% | 1.258% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical (NYSE:GMED) had its price target raised by analysts at Royal Bank Of Canada from $88.00 to $92.00. They now have an "outperform" rating on the stock.
Ratings data for GMED provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
06.11.24
06.11.24
€85.60
06.11.25
06.11.25
-
07.11.25
07.11.25
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
08.10.24
08.10.24
€72.86
08.10.25
08.10.25
-
09.10.25
09.10.25
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.26
07.08.24
07.08.24
€71.40
07.08.25
07.08.25
2361.54%
08.08.25
08.08.25
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.41
11.01.24
11.01.24
€63.93
11.01.25
11.01.25
1445.89%
12.01.25
12.01.25